1 Min Read
March 21 (Reuters) - BIOARCTIC AB:
* BIOARCTIC RECEIVES REGULATORY APPROVAL IN NORWAY FOR A CLINICAL STUDY IN PATIENTS WITH COMPLETE SPINAL CORD INJURY Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.